An artificial intelligence-generated R.E.N.A.L.+ score — developed by a team of researchers at Cleveland Clinic — proves superior to the traditional scoring system for the prediction of renal oncologic outcomes.
Study Demonstrates Association Between Urologic Oncology Fellowship Training and Diagnostic Yield on Prostate Biopsy
A new study shows that advanced urologic oncology training significantly increases a urologist’s likelihood of detecting prostate cancer via biopsy.
BCG Shortages Affect Bladder Cancer Care Decisions
A new Cleveland Clinic study documents the impacts that shortages of the immunotherapy agent Bacillus Calmette-Guerin have had on clinical management of non-muscle invasive bladder cancer. Urologic oncologist Robert Abouassaly, MD, discusses the findings and implications.